953
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Preoperative and postoperative evaluation of survivin in peripheral blood of patients with non-melanoma skin cancers. A pilot study

, , , &
Article: 2147390 | Received 21 Mar 2022, Accepted 10 Nov 2022, Published online: 19 Jan 2023
 

Disclosure statement

Dr. Tampouratzi reports personal fees from AbbVie, personal fees from LEO Pharma, personal fees from Janssen, personal fees from Sanofi, personal fees from Genesis Pharma, personal fees from UCB, personal fees from Mylan and personal fees from Novartis, outside the submitted work.

Dr. Asonitis reports there are no competing interests to declare.

Dr. Katsantonis reports personal fees from Abbvie, personal fees from UCB, personal fees from LEO Pharma, personal fees from Novartis, outside the submitted work.

Mr. Talaiporou reports there are no competing interests to declare.

Dr. Sfaelos reports there are no competing interests to declare.

Data availability statement

The data that support the findings of this study are available from the corresponding author, ET, upon reasonable request.